1. Home
  2. APM vs AZTR Comparison

APM vs AZTR Comparison

Compare APM & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • AZTR
  • Stock Information
  • Founded
  • APM 2010
  • AZTR 2014
  • Country
  • APM United Kingdom
  • AZTR United States
  • Employees
  • APM N/A
  • AZTR N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • AZTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • APM Health Care
  • AZTR Health Care
  • Exchange
  • APM Nasdaq
  • AZTR Nasdaq
  • Market Cap
  • APM 5.6M
  • AZTR 5.2M
  • IPO Year
  • APM 2018
  • AZTR 2023
  • Fundamental
  • Price
  • APM $0.99
  • AZTR $0.31
  • Analyst Decision
  • APM
  • AZTR
  • Analyst Count
  • APM 0
  • AZTR 0
  • Target Price
  • APM N/A
  • AZTR N/A
  • AVG Volume (30 Days)
  • APM 138.3K
  • AZTR 471.2K
  • Earning Date
  • APM 05-06-2025
  • AZTR 05-08-2025
  • Dividend Yield
  • APM N/A
  • AZTR N/A
  • EPS Growth
  • APM N/A
  • AZTR N/A
  • EPS
  • APM 0.00
  • AZTR N/A
  • Revenue
  • APM N/A
  • AZTR $7,500.00
  • Revenue This Year
  • APM $157,729.10
  • AZTR N/A
  • Revenue Next Year
  • APM N/A
  • AZTR N/A
  • P/E Ratio
  • APM $270.99
  • AZTR N/A
  • Revenue Growth
  • APM N/A
  • AZTR N/A
  • 52 Week Low
  • APM $0.46
  • AZTR $0.23
  • 52 Week High
  • APM $7.49
  • AZTR $12.00
  • Technical
  • Relative Strength Index (RSI)
  • APM 51.54
  • AZTR 50.54
  • Support Level
  • APM $0.79
  • AZTR $0.27
  • Resistance Level
  • APM $0.97
  • AZTR $0.35
  • Average True Range (ATR)
  • APM 0.12
  • AZTR 0.03
  • MACD
  • APM 0.02
  • AZTR 0.00
  • Stochastic Oscillator
  • APM 33.74
  • AZTR 60.00

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

Share on Social Networks: